TeleTrader 2/2/2022 Novartis' Q4 revenue hits expected $13.23 billion
GlobeNewswire 1/18/2022 Molecular Partners Finalizes License Agreement with Novartis for Ensovibep for COVID-19
TeleTrader 1/10/2022 Novartis drug 78% efficient against COVID - trial
GlobeNewswire 1/10/2022 Molecular Partners and Novartis Report Positive Topline Data from Phase 2 Study for Ensovibep (MP042...
GlobeNewswire 1/5/2022 Covis Completes Acquisition of Global Respiratory Portfolio of Two Medicines from AstraZeneca
GlobeNewswire 1/4/2022 Research Ethics Board approves amendment to Canadian Treatments for COVID-19 (CATCO) Trial to includ...
GlobeNewswire 12/17/2021 TMCF-Novartis US Foundation HBCU Alliance Accepting 2022 Faculty Grant Applications
GlobeNewswire 12/16/2021 Novartis initiates new USD 15 billion share buyback highlighting confidence in growth and pipeline
GlobeNewswire 12/14/2021 Molecular Partners Announces Collaboration with Novartis to Develop DARPin-Conjugated Radioligand Th...
GlobeNewswire 12/14/2021 Update on Novartis Agreement
GlobeNewswire 12/2/2021 Novartis R&D day spotlights attractive growth profile, underpinned by strong in-market brands, 20 po...
GlobeNewswire 12/1/2021 Arch Biopartners’ Lead Drug LSALT Peptide to Enter the Canadian Treatments for COVID-19 (CATCO) Tria...
TeleTrader 11/4/2021 Novartis to sell stake in Roche for $20.7 billion
TeleTrader 10/26/2021 Novartis: Q3 net sales up 5% to $13 billion
TeleTrader 7/21/2021 Novartis: Q2 net sales up 9% YoY at $12.9B
GlobeNewswire 7/14/2021 Dopavision Closes €12 Million Series A Round to Advance Digital Childhood Myopia Therapeutic Through...
TeleTrader 6/22/2021 EMA approves 2 more Pfizer jab production sites
GlobeNewswire 6/16/2021 Axtria Leads Discussion on Pharma’s Advanced Uses of Data Analytics and Artificial Intelligence With...
GlobeNewswire 6/10/2021 Arch Biopartners Files New Patent Application for Novel Antibody Candidates Targeting DPEP-1 Mediate...
GlobeNewswire 5/21/2021 XOMA Licensees to Present Significant Clinical Data at 2021 ASCO Annual Meeting
GlobeNewswire 5/17/2021 US Supreme Court denies Sandoz petition to review biosimilar Erelzi® (etanercept-szzs) case
GlobeNewswire 5/4/2021 Arch Biopartners Completes Enrollment in Phase II Trial of Metablok (LSALT Peptide) in Hospitalized ...
TeleTrader 4/27/2021 Novartis posts net sales of $12.41B in Q1
GlobeNewswire 4/21/2021 Ayala Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of AL102 in Combinatio...
TeleTrader 4/15/2021 Novartis to help Roche make potential COVID drug